After more than a year of missed opportunities, Senate Democrats are finally slated to pass a landmark, $740 billion reconciliation bill as soon as today that would grant Medicare the authority to negotiate the price of prescription drugs — a provision that has drawn a fresh round of fire from industry.
Source: Drug Industry Daily